This article was written by Follow Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor...
A nice counter-trade The latest gathering of the world’s political and business elite, plus the usual smattering of celebrities, is taking place this week...
When it comes to house flipping, the buyer should always beware. A house-flipping reality-show host and a life coach who has hawked self-help programs...
The moments between your milestones are not filler.”― Nelou Keramati. Today, we put Milestone Pharmaceuticals Inc. (NASDAQ:MIST) in the spotlight for the first time....
Ginkgo Bioworks’ (NYSE:DNA) first quarter results were something of a mixed bag, with continued progression on a number of metrics offset by rising costs...
Hello and welcome to Financial Face-off, a MarketWatch column where we help you weigh a financial decision. Our columnist will give her verdict. Tell...